137 related articles for article (PubMed ID: 7809341)
1. Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome.
Facchinetti F; Fioroni L; Martignoni E; Sances G; Costa A; Genazzani AR
Psychosom Med; 1994; 56(5):418-22. PubMed ID: 7809341
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome.
Rabin DS; Schmidt PJ; Campbell G; Gold PW; Jensvold M; Rubinow DR; Chrousos GP
J Clin Endocrinol Metab; 1990 Nov; 71(5):1158-62. PubMed ID: 2172272
[TBL] [Abstract][Full Text] [Related]
3. Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine.
Facchinetti F; Martignoni E; Fioroni L; Sances G; Genazzani AR
Cephalalgia; 1990 Feb; 10(1):51-6. PubMed ID: 2317851
[TBL] [Abstract][Full Text] [Related]
4. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
Inder WJ; Ellis MJ; Evans MJ; Donald RA
Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
[TBL] [Abstract][Full Text] [Related]
7. [-Effect of endogenous opioids on adrenal cortex activity in women with hypothalamic amenorrhea-].
Krause BT; Möller S
Gynakol Geburtshilfliche Rundsch; 1995; 35(4):194-8. PubMed ID: 8646002
[TBL] [Abstract][Full Text] [Related]
8. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
Schroeder S; Wichers M; Klingmüller D; Höfer M; Lehmann LE; von Spiegel T; Hering R; Putensen C; Hoeft A; Stüber F
Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311
[TBL] [Abstract][Full Text] [Related]
9. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
Inder WJ; Prickett TC; Mulder RT
Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
[TBL] [Abstract][Full Text] [Related]
10. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic-pituitary-adrenal axis in abdominal obesity: effects of dexfenfluramine.
Boushaki FZ; Rasio E; Serri O
Clin Endocrinol (Oxf); 1997 Apr; 46(4):461-6. PubMed ID: 9196609
[TBL] [Abstract][Full Text] [Related]
12. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson AJ; Jackson RV
J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
[TBL] [Abstract][Full Text] [Related]
13. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.
Scott LV; Burnett F; Medbak S; Dinan TG
Psychol Med; 1998 Mar; 28(2):285-93. PubMed ID: 9572086
[TBL] [Abstract][Full Text] [Related]
14. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.
Kudielka BM; Schmidt-Reinwald AK; Hellhammer DH; Kirschbaum C
Neuroendocrinology; 1999 Dec; 70(6):422-30. PubMed ID: 10657735
[TBL] [Abstract][Full Text] [Related]
15. Allopregnanolone serum concentrations and diurnal cortisol secretion in women with premenstrual dysphoric disorder.
Segebladh B; Bannbers E; Moby L; Nyberg S; Bixo M; Bäckström T; Sundström Poromaa I
Arch Womens Ment Health; 2013 Apr; 16(2):131-7. PubMed ID: 23329007
[TBL] [Abstract][Full Text] [Related]
16. Premenstrual syndrome is associated with altered cortisol awakening response.
Hou L; Huang Y; Zhou R
Stress; 2019 Nov; 22(6):640-646. PubMed ID: 31057066
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic amenorrhea: evidence for a central derangement of hypothalamic-pituitary-adrenal cortex axis activity.
Nappi RE; Petraglia F; Genazzani AD; D'Ambrogio G; Zara C; Genazzani AR
Fertil Steril; 1993 Mar; 59(3):571-6. PubMed ID: 8384575
[TBL] [Abstract][Full Text] [Related]
18. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
[TBL] [Abstract][Full Text] [Related]
19. Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls.
Roca CA; Schmidt PJ; Altemus M; Deuster P; Danaceau MA; Putnam K; Rubinow DR
J Clin Endocrinol Metab; 2003 Jul; 88(7):3057-63. PubMed ID: 12843143
[TBL] [Abstract][Full Text] [Related]
20. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
